↓ Skip to main content

Sotatercept: A First-In-Class Activin Signaling Inhibitor for Pulmonary Arterial Hypertension

Overview of attention for article published in Journal of Pharmacy Technology, February 2025
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#15 of 425)
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news
3 news outlets
patent
1 patent
bluesky
1 Bluesky user

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Sotatercept: A First-In-Class Activin Signaling Inhibitor for Pulmonary Arterial Hypertension
Published in
Journal of Pharmacy Technology, February 2025
DOI 10.1177/87551225251317957
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Bachelor 4 16%
Researcher 3 12%
Student > Doctoral Student 2 8%
Student > Ph. D. Student 2 8%
Unspecified 1 4%
Other 1 4%
Unknown 12 48%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 7 28%
Social Sciences 2 8%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Unspecified 1 4%
Biochemistry, Genetics and Molecular Biology 1 4%
Other 3 12%
Unknown 10 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 July 2026.
All research outputs
#1,723,498
of 34,217,933 outputs
Outputs from Journal of Pharmacy Technology
#15
of 425 outputs
Outputs of similar age
#21,856
of 361,639 outputs
Outputs of similar age from Journal of Pharmacy Technology
#2
of 9 outputs
Altmetric has tracked 34,217,933 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 425 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.8. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,639 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.